All studies
Pediatric and FamilyPhase IIIEnrolling Soon

Investigational Therapy for Pediatric Moderate Persistent Asthma

Assessing the safety and asthma control of an investigational add-on therapy in children with moderate persistent asthma despite standard controller medication.

Time commitment

52 weeks

Compensation

Up to $1,500

Site

PRIME Trials — Downtown

Who may qualify

Children 6–17 with moderate persistent asthma on a stable inhaled corticosteroid.

Step 1 of 1

Enroll in this study

Answer a few quick questions below and a study coordinator will call you to confirm eligibility. It takes about a minute and there is no obligation.

Start Enrollment

Investigational Therapy for Pediatric Moderate Persistent Asthma

Step 1 of 4Takes ~1 minute

Enter your ZIP code so we can match you to the nearest site.

Prefer to talk now?

Call or text our team and we will walk you through this study.